Loading…
Loading…
EQUITY / NASDAQ · XNCM
ProMIS Neurosciences Inc.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗9.4 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 9.4 USD · Volume 27,809
250 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Operating profit | -12,266,399 USD | — | — |
| Net income | -11,729,656 USD | — | — |
| Cash and cash equivalents | 53,429,280 USD | — | — |
| Total liabilities | 7,294,999 USD | — | — |
| Total equity | 49,398,934 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 203/31/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 101/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 53,429,280 USD | — | — | 63,814,345 USD | 6,116,556 USD | 6,116,556 USD | 15,399,165 USD | — |
| Net incomeIncome statement | -11,729,656 USD | -19,974,029 USD | — | -8,244,372 USD | — | -39,719,147 USD | -11,580,126 USD | -29,045,059 USD |
| Operating profitIncome statement | -12,266,399 USD | -20,911,296 USD | — | -8,644,895 USD | — | -40,167,308 USD | -11,750,432 USD | -29,395,189 USD |
| Total assetsBalance sheet | 56,693,933 USD | — | — | 67,411,571 USD | 9,182,421 USD | 9,182,421 USD | 21,458,147 USD | — |
| Total equityBalance sheet | 49,398,934 USD | — | 60,717,571 USD | 60,717,572 USD | -1,258,592 USD | -1,258,592 USD | 9,187,355 USD | — |
| Total liabilitiesBalance sheet | 7,294,999 USD | — | — | 6,693,999 USD | 10,441,013 USD | 10,441,013 USD | 12,270,792 USD | — |
| Financing cash flowCash flow statement | — | 70,081,309 USD | — | 70,081,309 USD | — | 20,944,670 USD | — | 20,944,671 USD |
| Operating cash flowCash flow statement | — | -22,768,585 USD | — | -12,383,520 USD | — | -28,118,579 USD | — | -18,836,673 USD |
| Investing cash flowCash flow statement | — | — | — | — | — | -702 USD | — | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 05/12/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/25/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.